{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T12:47:49Z","timestamp":1782046069211,"version":"3.54.5"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2681352","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:57:11Z","timestamp":1782043031000},"page":"1701-1713","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-na\u00efve people with multiple sclerosis"],"prefix":"10.1080","volume":"29","author":[{"given":"Jeffrey","family":"Kaplan","sequence":"first","affiliation":[{"name":"Kansas City Multiple Sclerosis and Headache Center","place":["Roeland Park, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Beenstock","sequence":"additional","affiliation":[{"name":"Linda E. Cardinale Multiple Sclerosis Center","place":["Freehold, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Belkin","sequence":"additional","affiliation":[{"name":"Michigan Institute for Neurological Disorders","place":["Farmington Hills, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6785-8155","authenticated-orcid":false,"given":"Heidi","family":"Crayton","sequence":"additional","affiliation":[{"name":"MS Center of Greater Washington","place":["Vienna, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-3972","authenticated-orcid":false,"given":"Christopher","family":"Eckstein","sequence":"additional","affiliation":[{"name":"Department of Neuroimmunology and MS, Duke University","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Fredericks","sequence":"additional","affiliation":[{"name":"St. Dominic Neuroscience Center","place":["Jackson, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-4218","authenticated-orcid":false,"given":"Boyang","family":"Bian","sequence":"additional","affiliation":[{"name":"Biogen","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-3418","authenticated-orcid":false,"given":"Nicholas","family":"Belviso","sequence":"additional","affiliation":[{"name":"Biogen","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Ni","sequence":"additional","affiliation":[{"name":"Biogen","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danette","family":"Rutledge","sequence":"additional","affiliation":[{"name":"Biogen","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30959-x"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649502"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0041-4"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000000560"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01570-0"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00965-7"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105751"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2023.06.004"},{"key":"e_1_3_6_10_1","unstructured":"Tysabri [prescribing information]. Biogen Inc. 2025 Mar [cited 2026 Jan 26]. Available from: https:\/\/www.tysabrihcp.com\/content\/dam\/commercial\/tysabri\/hcp\/en_us\/pdf\/tysabri_prescribing_information.pdf"},{"key":"e_1_3_6_11_1","unstructured":"Ocrevus [prescribing information]. Genentech Inc. 2025 Aug [cited 2026 Jan 26]. Available from: https:\/\/www.gene.com\/download\/pdf\/ocrevus_prescribing.pdf"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00537"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06608-z"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27143"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221142924"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.88.16_supplement.P2.052"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102539"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102741"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864231221331"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/cpj.0000000000000227"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.1743"},{"key":"e_1_3_6_24_1","unstructured":"Newsome SD Cerqueira J Centonze D et al. No evidence of disease activity in treatment\u2011na\u00efve people with relapsing multiple sclerosis treated with intravenous or subcutaneous ocrelizumab: findings of the OPERA (10 years) and OCARINA II (2 years) studies. Presented at Americas Committee for Treatment and Research in Multiple Sclerosis Forum; Poster P125; 2026."},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221078825"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106886"},{"key":"e_1_3_6_27_1","unstructured":"Steinman L Fox EJ Hartung HP et al. Disease outcomes with ublituximab in treatment\u2011na\u00efve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in relapsing multiple sclerosis. Presented at: 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; 2022."},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52118"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000012753"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26028"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2581"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.23039"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12305-4"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(20)30067-3"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000204375"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2681352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13696998.2026.2681352","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2681352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:57:18Z","timestamp":1782043038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2681352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2681352"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2681352","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}